Ping Wen

796 total citations
33 papers, 601 citations indexed

About

Ping Wen is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ping Wen has authored 33 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 11 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ping Wen's work include Ferroptosis and cancer prognosis (3 papers), Cancer Cells and Metastasis (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Ping Wen is often cited by papers focused on Ferroptosis and cancer prognosis (3 papers), Cancer Cells and Metastasis (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Ping Wen collaborates with scholars based in China, United States and Poland. Ping Wen's co-authors include Wolfgang Sadée, Duxin Sun, Xianhua Cao, Zunyan Dai, Ying Huang, Seth Gibbs, Lanyan Fang, Xincheng Zheng, Wendy L. Frankel and Manju L. Prasad and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Ping Wen

31 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ping Wen China 12 296 211 203 98 85 33 601
Matthias Neid Germany 10 281 0.9× 180 0.9× 190 0.9× 101 1.0× 84 1.0× 30 599
Sarah Gunningham New Zealand 12 419 1.4× 235 1.1× 304 1.5× 83 0.8× 119 1.4× 13 736
Shanna A. Arnold United States 12 228 0.8× 143 0.7× 334 1.6× 77 0.8× 96 1.1× 18 773
Jang‐Seong Kim South Korea 14 337 1.1× 179 0.8× 132 0.7× 119 1.2× 92 1.1× 27 662
Biao Liu China 17 276 0.9× 200 0.9× 176 0.9× 70 0.7× 209 2.5× 36 602
Valerie A. Siclari United States 9 341 1.2× 120 0.6× 281 1.4× 86 0.9× 90 1.1× 10 658
Arja Jukkola‐Vuorinen Finland 15 196 0.7× 145 0.7× 202 1.0× 133 1.4× 61 0.7× 40 687
Enrique Grande Pulido Spain 11 229 0.8× 100 0.5× 220 1.1× 70 0.7× 93 1.1× 35 530
Gabriella Gaudioso Italy 16 369 1.2× 228 1.1× 221 1.1× 114 1.2× 156 1.8× 29 778

Countries citing papers authored by Ping Wen

Since Specialization
Citations

This map shows the geographic impact of Ping Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Wen more than expected).

Fields of papers citing papers by Ping Wen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Wen. The network helps show where Ping Wen may publish in the future.

Co-authorship network of co-authors of Ping Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Ping Wen. A scholar is included among the top collaborators of Ping Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ping Wen. Ping Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wen, Ping, Ningning Zhang, Qing Shao, et al.. (2025). Knowledge mapping of tumor microenvironment for breast cancer: a bibliometric analysis from 2014 to 2023. Frontiers in Immunology. 16. 1550988–1550988. 1 indexed citations
2.
Li, Sisi, et al.. (2024). Research hotspots and trends of epigenetic therapy in oncology: a bibliometric analysis from 2004 to 2023. Frontiers in Pharmacology. 15. 1465954–1465954. 1 indexed citations
3.
Wen, Ping, Jan Drappatz, R. Jena, et al.. (2024). Safety and Preliminary Efficacy of AZD1390 + Radiation Therapy for Glioblastoma. International Journal of Radiation Oncology*Biology*Physics. 120(2). S119–S120. 4 indexed citations
4.
Wen, Ping, et al.. (2024). Value of the HOTAIR expression assay in predicting therapy target in hepatocellular carcinoma: A meta-analysis and bioinformatics analysis. The International Journal of Biological Markers. 39(3). 239–247. 1 indexed citations
6.
Wang, Guanwen, Ping Wen, Ting Xue, et al.. (2024). Her2 promotes early dissemination of breast cancer by inhibiting the p38 pathway through the downregulation of MAP3K4. Cell Communication and Signaling. 22(1). 611–611. 2 indexed citations
7.
Qu, Fanli, et al.. (2024). Knowledge mapping of immunotherapy for breast cancer: A bibliometric analysis from 2013 to 2022. Human Vaccines & Immunotherapeutics. 20(1). 2335728–2335728. 18 indexed citations
8.
Wen, Ping, Wei Wu, Hanqi Zheng, et al.. (2022). Cell delivery devices for cancer immunotherapy. Journal of Controlled Release. 353. 875–888. 10 indexed citations
9.
Zhong, Wen, et al.. (2021). A Cancer Cell Cluster Marked by LincRNA MEG3 Leads Pancreatic Ductal Adenocarcinoma Metastasis. Frontiers in Oncology. 11. 656564–656564. 11 indexed citations
10.
Wen, Ping, et al.. (2021). A retrospective study of hypofractionated radiotherapy for keloids in 100 cases. Scientific Reports. 11(1). 3598–3598. 9 indexed citations
11.
Li, Meng, et al.. (2020). Treatment and toxic effects of prophylactic cranial irradiation in stage II–III non–small cell lung cancer: A meta‐analysis. Asia-Pacific Journal of Clinical Oncology. 17(2). e18–e26. 4 indexed citations
12.
Wen, Ping, et al.. (2020). Meta-analysis of prophylactic cranial irradiation or not in treatment of extensive-stage small-cell lung cancer: The dilemma remains. Cancer/Radiothérapie. 24(1). 44–52. 8 indexed citations
13.
Wang, Guiliang, Yan Liu, Shu‐Feng Zhou, et al.. (2016). Sorafenib combined with transarterial chemoembolization in patients with hepatocellular carcinoma: a meta-analysis and systematic review. Hepatology International. 10(3). 501–510. 27 indexed citations
14.
Cui, Wenyu, et al.. (2014). A meta-analysis of bevacizumab combined with chemotherapy in the treatment of ovarian cancer. Indian Journal of Cancer. 51(7). 95–95. 9 indexed citations
15.
Ren, Yutang, Meiyun Ke, Xiucai Fang, et al.. (2012). Response of Esophagus to High and Low Temperatures in Patients With Achalasia. Journal of Neurogastroenterology and Motility. 18(4). 391–398. 13 indexed citations
17.
Bhardwaj, Atul, Wendy L. Frankel, Natalia S. Pellegata, Ping Wen, & Manju L. Prasad. (2008). Intracellular Versican Expression in Mesenchymal Spindle Cell Tumors Contrasts With Extracellular Expression in Epithelial and Other Tumors—A Tissue Microarray-based Study. Applied immunohistochemistry & molecular morphology. 16(3). 263–266. 6 indexed citations
18.
Nash, Jason W., Atul Bhardwaj, Ping Wen, & Wendy L. Frankel. (2007). Maspin is Useful in the Distinction of Pancreatic Adenocarcinoma From Chronic Pancreatitis. Applied immunohistochemistry & molecular morphology. 15(1). 59–63. 14 indexed citations
19.
Prasad, Manju L., Cátálin Bárbácioru, Yeshwant B. Rawal, Omar F. Husein, & Ping Wen. (2007). Hierarchical cluster analysis of myoepithelial/basal cell markers in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma. Modern Pathology. 21(2). 105–114. 39 indexed citations
20.
Cao, Xianhua, Lanyan Fang, Seth Gibbs, et al.. (2006). Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia. Cancer Chemotherapy and Pharmacology. 59(4). 495–505. 190 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026